This GYA Working Group focuses on biodiversity conservation from a biomedical perspective. The aims are to preserve knowledge about the medicinal properties of different species, create a global knowledge hub for biodiversity and biomedicine, and develop new pharmaceuticals from nature while protecting biodiversity.
The loss of biodiversity minimises the potential for harvesting new medicines and for future medical discoveries. This is due to the interdependence of sustainability of the environment, human wellbeing, and the development of new public health practices. The actions of our group will mobilise the skills and expertise within the GYA to address this issue. In addition, the Bio2Bio incubator group aims to create practical recommendations for the sustainable use of Earth’s finite natural resources for healing purposes and requests the support from policymakers. With the expanding loss of biodiversity, we must act now to avoid losing new solutions for human-focused problems.
For GYA members and alumni only: connect to the group, collaborate and discuss with other members on the GYA-internal Agora platform here.
The group is working on forming a network of research activities (finding new lead compounds from indigenous species) and establishing a library of compounds.